CompletedPhase 4ketamine

Alternative Sedation During Bronchoscopy

Sponsored by University of Pennsylvania

NCT ID
NCT01158820
Target Enrollment
50 participants
Start Date
2010-06
Est. Completion
2012-05

About This Study

This protocol hopes to determine whether the use of dexmedetomidine-ketamine can reduce the use of standard of care fentanyl-midazolam sedation during bronchoscopy. This may result in less respiratory depression while providing better compliance with the procedure.

Conditions Studied

Sedation

Interventions

  • Dexmedetomidine load
  • Ketamine load
  • Midazolam load
  • Fentanyl load
  • Dexmedetomidine maintenance
  • Ketamine maintenance
  • Midazolam demand
  • Fentanyl demand
  • Benadryl demand

Eligibility

Age:18 Years - 90 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Adults over the age of 18 scheduled for elective flexible bronchoscopy in the endoscopy suite or OR of HUP

Exclusion Criteria:

* History of inability to complete bronchoscopy attributable to inadequate sedation
* Requiring more than 2 LPM supplemental oxygen to maintain SaO2 \> 90%
* History of allergy to study medications
* Pregnancy
* A history of psychosis
* Any condition deemed likely by the pulmonologist or anesthesiologist to pose a significant risk due to elevation of blood pressure, including cerebral/aortic aneurysm, and or ischemic cardiovascular disease
* Bradydysrhythmia deemed significant by the anesthesiologist or pulmonologist
* A diagnosis of significant renal or hepatic impairment

Study Locations (1)

University of Pennsylvania
Philadelphia, Pennsylvania, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source